Correlation Between Neximmune and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Neximmune and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Virax Biolabs Group, you can compare the effects of market volatilities on Neximmune and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Virax Biolabs.
Diversification Opportunities for Neximmune and Virax Biolabs
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neximmune and Virax is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Neximmune i.e., Neximmune and Virax Biolabs go up and down completely randomly.
Pair Corralation between Neximmune and Virax Biolabs
If you would invest 243.00 in Neximmune on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Neximmune or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Neximmune vs. Virax Biolabs Group
Performance |
| Timeline |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Virax Biolabs Group |
Neximmune and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neximmune and Virax Biolabs
The main advantage of trading using opposite Neximmune and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
| Virax Biolabs vs. Tff Pharmaceuticals | Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. Inhibrx | Virax Biolabs vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |